Ecuador Medical Device Registration 2026: Official Fees and Payment Rules

1. Key takeaways

Article 8 of the new regulation provides that registration, renewal and changes are all subject to the fees (tasas) established in the current fee schedule issued by ARCSA for that purpose. The amounts are not written into the body of the technical regulation; they are published in separate fee resolutions of ARCSA. Two official fee facts can be cited directly: the reclassification application for existing devices carries no fee whatsoever (transitory provision two), and the voluntary cancellation application carries no fee (final paragraph of Article 47).

2. Legal basis

Industry figures (non-official; the current ARCSA publication prevails): the official fee for registration of imported products is reported at approximately USD 904.34 per product, approximately USD 678.25 for domestic products, approximately USD 90 to 95 for changes, and approximately USD 181 to 185 for renewals. These amounts are consistently cited by several industry bodies as the ARCSA fee schedule. The current fee table published on the ARCSA website was not directly retrieved for this edition, and any citation must be labeled as an industry practical estimate.

3. Expert insights

Insight 1: Keeping the amounts out of the regulation is a deliberate institutional design, not a drafting oversight. Article 8 contains only an enabling provision, with the amounts published separately in ARCSA fee resolutions. The practical effect of this structure is that official fees can be adjusted without amending the technical regulation itself, so companies cannot anticipate fee movements from changes to the registration regulation. Budget owners should treat the fee schedule as a living input with its own review cycle, decoupled from the lifecycle of the technical regulation.

Insight 2: Article 138 is the legal source of the fee authority. Article 138 of the Health Law authorizes the collection of fees for statutory procedures, and on that basis a ministerial agreement (Acuerdo Ministerial 112, Registro Oficial No. 298, 2008-03-19) was adopted as the fee protocol. The technical regulation and the fee resolutions together form the complete chain of fee authority.

Insight 3: Payment falls due after review, which is an advantage at the cash flow level. Article 26(5) and Article 35(5) are aligned: once the review is passed, the system notifies the amount, and the applicant has 10 statutory periods to pay. No payment is required at submission, so the cash exposure of a failed project is limited. This sequencing also means the fee actually paid always corresponds to the tariff in force at the moment of approval, which reinforces the need to re-check amounts close to payment rather than at filing.

Insight 4: However, Article 18 creates a no-refund exception. Where an application is declared withdrawn because of an incorrect deficiency response or a missed deficiency deadline, fees already paid are not refunded. This exception covers precisely the most common causes of failure. Since the deficiency response window is short and granted only once, the internal review of a response before submission is the cheapest fee protection measure available to an applicant.

Insight 5: The two official no-fee items carry substantive value. Transitory provision two states expressly that reclassification change applications for existing products are not subject to any payment (no estará sujeta a pago alguno), and the final paragraph of Article 47 states expressly that the voluntary cancellation application carries no fee. Against the background of large-scale reclassification of existing products after 2027-01-28, the former can save companies with multiple product lines a considerable outlay. For a portfolio of dozens of registrations, routing every reclassification through the free change channel instead of a paid pathway changes the total compliance budget materially.

Insight 6: ISO 13485 registration is a separately charged item. Article 62 provides that the registration procedure is submitted through the document management system (Quipux), generating a separate payment order payable within the prescribed period. This charge is independent of the registration fee. Companies budgeting the domestic pathway should therefore expect two distinct payment documents for the same product, and reconcile both against their fee ledger to avoid an unpaid item blocking the file.

4. Practical recommendations

1. Request the current fee resolution text from ARCSA when preparing the budget, and do not rely on historical amounts.
2. Plan cash flow around payment after review, reserving a payment window of 10 statutory periods.
3. Use the two official no-fee items: route reclassification of existing products through the change channel, and market exits through voluntary cancellation, neither of which generates a fee.
4. Treat the deficiency response success rate as the fee risk control point, to avoid fee loss under Article 18.
5. Budget the ISO 13485 registration fee separately on the domestic pathway, kept apart from the registration fee line.

5. Verification checklist

• □ The current ARCSA fee resolution text has been obtained and used for budgeting
• □ The payment deadline after review has been confirmed as 10 statutory periods
• □ The no-refund risk on failed deficiency responses has been confirmed (Article 18)
• □ Reclassification of existing products has been planned through the free change channel
• □ Voluntary cancellation needs have been confirmed against the no-fee provision
• □ The ISO 13485 registration fee on the domestic pathway has been budgeted separately

Regulatory information verified as of October 29, 2026

GRZAN service note

GRZAN provides regulatory support in this country for medical device manufacturers, importers and authorized representatives, covering registration pathway planning, official fee and timeline estimation, licensing structure design, payment window management, technical dossier preparation, and post-market compliance management. Manufacturers and importers building a fee budget for Ecuador registration or reviewing fee exposure may contact GRZAN at info@grzanglobal.com for a tailored solution.